Versant Capital Management’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
Other funds holding MLAB
LPP
RIM
Versant Capital Management's MLAB Position: Q2 2026 in Review
Versant Capital Management increased its Mesa Laboratories (MLAB) stake by 6.9% in Q2 2026, buying an estimated $906 and bringing the position to 139 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2112.
Versant Capital Management first reported a position in MLAB in Q1 2020 and has held it in 21 quarters since. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.
- Versant Capital Management held 139 shares of Mesa Laboratories worth $13.8K as of Q2 2026.
- Versant Capital Management bought 9 Mesa Laboratories shares in Q2 2026, an estimated $906.
- Mesa Laboratories made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2112 holding.
- Versant Capital Management first reported a position in Mesa Laboratories in Q1 2020 and has held it in 21 quarters since.
- 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.